Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Treatments received by the patients and SLEDAI score at the time of analysis

From: Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients

  Patient characteristics    
Patient Sex Daily prednisone dose* Other treatment SLEDAI** %CD27+IgD+
1 F LOW HCQ 4 7
2 F MEDIUM CYC 16 9
3 F HIGH - 8 1
4 F LOW - 4 3
5 F - HCQ 2 7
6 F LOW - 15 3
7 F - HCQ 0 4
8 F HIGH AZA 10 5
9 F - - 0 8
10 F - HCQ 0 11
11 F - HCQ 0 17
12 F LOW MMF 10 4
13 F HIGH AZA 1 3
14 F - HCQ 2 3
15 F MEDIUM HCQ 8 8
16 F HIGH HCQ 0 13
17 F - - 0 8
18 M LOW HCQ 4 12
19 F LOW HCQ 2 6
20 F LOW - 0 2
21 F MEDIUM HCQ 5 7
22 F HIGH HCQ 19 9
23 F LOW - 8 2
24 F LOW - 4 21
25 F - - 0 7
26 F LOW AZA 1 7
27 M LOW AZA 0 13
28 F - HCQ 0 18
29 F - - 11 6
30 F - HCQ 13 3
31 F LOW AZA 0 4
32 M - - 0 6
33 F - HCQ 4 8
34 F LOW HCQ 8 4
35 M HIGH - 8 6
36 F - HCQ 0 11
37 F - HCQ 0 25
38 F - - 3 8
39 F - HCQ 1 27
40 F - AZA/RX 0 2
41 F - - 0 24
42 F - HCQ 0 4
43 F - - 0 6
44 F - MTX 0 8
45 F - - 0 13
46 F - - 0 28
47 F - HCQ 0 2
48 F LOW HCQ 0 16
49 F - HCQ 1 5
50 F - - 0 3
51 F - HCQ/MTX 0 8
52 F - HCQ 0 17
53 F - - 0 33
54 F - HCQ 0 6
55 F LOW MMF 4 15
56 F - HCQ 0 8
57 M - LFN 4 31
58 F - LFN 0 10
59 F LOW MTX 4 5
60 F LOW MTX 0 5
61 F - - 0 4
62 F - HCQ 1 7
63 F LOW MMF 0 15
64 F - - 0 3
65 F MEDIUM HCQ/MTX 2 2
66 M LOW - 0 13
67 F LOW - 0 13
68 F - - 0 17
69 F - AZA 1 4
  1. *LOW (≤10 mg/day); MEDIUM (≤30 mg/day); HIGH (>30 mg/day).
  2. AZA: azathioprine; HQC: hydroxychloroquine; CYC: cyclophosphamide; LFN: leflunomide MMF: mycophenolate mofetil; MTX: methotrexate; RX: rituximab; **SLEDAI: Systemic Lupus Erythematosus Disease Activity Index.